Finance Gilead Sciences, Inc. (GILD)’s Breast Cancer Study Success Drives Investor Optimism Amid Broader Market SlumpMay 24, 20250 Gilead Sciences, Inc. (NASDAQ:GILD) has revealed encouraging outcomes from its ASCENT-03 scientific trial, showcasing a significant breakthrough in treating metastatic…
